Bright Green Corporation

BGXX

US10920G1004

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 01:36:47 2024-04-23 pm EDT			5-day change	1st Jan Change
0.201 ^USD	-5.32%		-5.85%	-35.69%

Apr. 16	Bright Green Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 14	Bright Green Corporation Announces Its Expansion Continues with A $100 Million Solar Power Generation Field to Supply the Heat and Electricity to Its Drug Production and Manufacturing Facility	CI

Bright Green Corporation Announces Stepping Down of Ed Robinson as Member of the Board of Directors

July 01, 2022 at 04:30 pm EDT

Bright Green Corporation announced that Ed Robinson is stepping down as a member of the Board of Directors (Board), to pursue other opportunities. Mr. Robinson will remain with the Company as a Capital Markets Advisor through 2023.

Latest news about Bright Green Corporation

Bright Green Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Bright Green Corporation Announces Its Expansion Continues with A $100 Million Solar Power Generation Field to Supply the Heat and Electricity to Its Drug Production and Manufacturing Facility	Mar. 14	CI
Bright Green Shares Soar on $250 Million Expansion of Drug Production Facility in New Mexico	Mar. 12	MT
Bright Green Corporation Announces Plans for $250 Million Expansion of Its Controlled Substances Drug Production Facility in Grants, New Mexico	Mar. 12	CI
Bright Green Corporation Enters into a Credit Agreement	Mar. 12	CI
Bright Green Corporation Announces Board Changes	Mar. 11	CI
Bright Green Corporation Receives Final Approval from the New MexicoBoard of Pharmacy and the DEA	Feb. 22	CI
Bright Green Corporation Appoints Groovy Singh as Chief Executive Officer	Jan. 14	CI
'Born into horrors' - Gaza newborns suffer in war	Dec. 18	RE
Unwashed and underfed, babies born into Gaza war face hardship in tents	Dec. 18	RE
North American Morning Briefing : Stock Futures -2-	Nov. 27	DJ
Bright Green Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Bright Green Appoints New CEO	23-10-03	MT
Bright Green Corporation Announces CEO Changes	23-10-03	CI
Extreme plankton bloom creates marine 'dead zone' off eastern Thailand	23-09-19	RE
PA police say fugitive stole van, eluded perimeter	23-09-10	RE
Insider Sell: Bright Green	23-09-06	MT
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	23-08-25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	23-08-18	DJ
Bright Green Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
North American Morning Briefing : Stock Futures -2-	23-08-11	DJ
Tech Sector Poised for Better-Than-Expected Earnings Season Amid AI Boom, Wedbush Says	23-07-11	MT
Bright Green Set to Join Russell 3000 Index; Shares Rise	23-06-23	MT
Bright Green Files Registration Statement on Behalf of Selling Stockholder for Offering of up to 7.4 Million Common Shares	23-06-06	MT
Bright Green Closes $3.5 Million Private Placement	23-05-25	MT

Chart Bright Green Corporation

Duration

Period

More charts

Company Profile

Bright Green Corporation is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and as an active ingredient to consumer-based solutions. The Company is engaged in cannabis propagation, cultivation, and manufacturing of cannabis products, including cannabis flower, pre-rolls, concentrates, vape pens, capsules, tinctures, edibles, topicals and any other cannabis-related products requested for authorized sales. The Company plans to sell extracted oils from medicinal plants grown in these high-tech facilities and processed onsite through a system that vertically integrates the genetically altered growth of the plants to conform to automated growing systems. It also plans to cultivate and manufacture cannabis for federally sanctioned research, as well as perform authorized research on cannabis, including cannabinol (CBN), cannabigerol (CBG), and cannabidiol (CBD).

Sector

Pharmaceuticals

Calendar

2024-05-21 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BRIGHT GREEN CORPORATION	-35.69%	37.67M
ELI LILLY AND COMPANY	+27.19%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.22%	359B
MERCK & CO., INC.	+16.47%	322B
ABBVIE INC.	+9.78%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.91%	149B